{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T17:18:26Z","timestamp":1794158306245,"version":"4.8.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0108074"],"award-info":[{"award-number":["JP20fk0108074"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016981","name":"Pharmaceutical Society of Japan","doi-asserted-by":"publisher","award":["US 11,186,618"],"award-info":[{"award-number":["US 11,186,618"]}],"id":[{"id":"10.13039\/100016981","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17H04009"],"award-info":[{"award-number":["JP17H04009"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K19401"],"award-info":[{"award-number":["JP18K19401"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H03404"],"award-info":[{"award-number":["JP20H03404"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K21480"],"award-info":[{"award-number":["JP20K21480"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019670","name":"BIKEN Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.isci.2022.105324","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T12:28:17Z","timestamp":1665404897000},"page":"105324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficient antigen delivery by dendritic cell-targeting peptide via nucleolin confers superior vaccine effects in mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Teppei","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Misato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Tamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Akeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuhiko","family":"Nakase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsushi","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokichi","family":"Takahama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko N.","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7265-9221","authenticated-orcid":false,"given":"Yasuo","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2022.105324_bib1","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.bbagen.2016.12.015","article-title":"G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: uses and mechanisms","volume":"1861","author":"Bates","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.isci.2022.105324_bib2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2012.11.020","article-title":"Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype","volume":"38","author":"Baumjohann","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2022.105324_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4161\/mabs.12187","article-title":"Mining human antibody repertoires","volume":"2","author":"Beerli","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.isci.2022.105324_bib4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4049\/jimmunol.1002881","article-title":"A unique role of the cholera toxin A1-DD adjuvant for long-term plasma and memory B cell development","volume":"186","author":"Bemark","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib5","doi-asserted-by":"crossref","first-page":"e06994","DOI":"10.7554\/eLife.06994","article-title":"Antigen presentation kinetics control T\u00a0cell\/dendritic cell interactions and follicular helper T\u00a0cell generation in\u00a0vivo","volume":"4","author":"Benson","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.isci.2022.105324_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biochi.2015.03.023","article-title":"The roles of nucleolin subcellular localization in cancer","volume":"113","author":"Berger","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.isci.2022.105324_bib7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20021598","article-title":"Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T\u00a0cell tolerance","volume":"196","author":"Bonifaz","year":"2002","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2022.105324_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12343","article-title":"Fcgamma receptor pathways during active and passive immunization","volume":"268","author":"Bournazos","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.isci.2022.105324_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-immunol-051116-052433","article-title":"Signaling by antibodies: recent progress","volume":"35","author":"Bournazos","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib10","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.isci.2022.105324_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.it.2011.10.007","article-title":"Boosting antibody responses by targeting antigens to dendritic cells","volume":"33","author":"Caminschi","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib12","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3389\/fimmu.2019.01839","article-title":"Delivery of antigen to CD8(+) dendritic cells by fusing antigen with formyl peptide receptor-like 1 inhibitor protein induces antitumor immunity","volume":"10","author":"Chiang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib13","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/biom11081072","article-title":"Platforms for production of protein-based vaccines: from classical to next-generation strategies","volume":"11","author":"Cid","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.isci.2022.105324_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.coi.2017.06.008","article-title":"Germinal center enhancement by extended antigen availability","volume":"47","author":"Cirelli","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib15","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.cell.2019.04.012","article-title":"Slow delivery immunization enhances HIV neutralizing antibody and germinal center responses via modulation of immunodominance","volume":"177","author":"Cirelli","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.isci.2022.105324_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib17","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/emmm.201403876","article-title":"Vaccines for the 21st century","volume":"6","author":"Delany","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2022.105324_bib18","doi-asserted-by":"crossref","first-page":"232ra251","DOI":"10.1126\/scitranslmed.3008068","article-title":"Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205","volume":"6","author":"Dhodapkar","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2022.105324_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","article-title":"Dendritic cell subsets in T\u00a0cell programming: location dictates function","volume":"19","author":"Eisenbarth","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib20","doi-asserted-by":"crossref","first-page":"322001","DOI":"10.1088\/1361-6528\/abfb30","article-title":"Cell surface nucleolin as active bait for nanomedicine in cancer therapy: a promising option","volume":"32","author":"Ferrara","year":"2021","journal-title":"Nanotechnology"},{"key":"10.1016\/j.isci.2022.105324_bib21","first-page":"450","article-title":"A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells","volume":"60","author":"Fukuda","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2022.105324_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-gamma: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib23","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.7150\/thno.56406","article-title":"Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk\/IL-21 axis","volume":"11","author":"Gou","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2022.105324_bib24","first-page":"785634","article-title":"Pros and cons of antigen-presenting cell targeted tumor vaccines","volume":"2015","author":"Goyvaerts","year":"2015","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.isci.2022.105324_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41590-017-0007-9","article-title":"Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic","volume":"19","author":"Graham","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nm987","article-title":"Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration","volume":"10","author":"Heikenwalder","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2022.105324_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-018-0089-x","article-title":"Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want","volume":"3","author":"HogenEsch","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.isci.2022.105324_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1380-2933(98)00007-4","article-title":"Antibody phage display technology and its applications","volume":"4","author":"Hoogenboom","year":"1998","journal-title":"Immunotechnology"},{"key":"10.1016\/j.isci.2022.105324_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/cancers11030418","article-title":"Use of dendritic cell receptors as targets for enhancing anti-cancer immune responses","volume":"11","author":"Hossain","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2022.105324_bib30","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1073\/pnas.1019547108","article-title":"Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A","volume":"108","author":"Idoyaga","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2022.105324_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.addr.2020.06.019","article-title":"Controlling timing and location in vaccines","volume":"158","author":"Irvine","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.isci.2022.105324_bib32","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nmat3775","article-title":"Engineering synthetic vaccines using cues from natural immunity","volume":"12","author":"Irvine","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.isci.2022.105324_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1074-7613(03)00175-4","article-title":"Distinct dendritic cell populations sequentially present antigen to CD4 T\u00a0cells and stimulate different aspects of cell-mediated immunity","volume":"19","author":"Itano","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2022.105324_bib34","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3389\/fmicb.2017.00742","article-title":"Towards identifying protective B-cell epitopes: the PspA story","volume":"8","author":"Khan","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2022.105324_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coi.2019.02.008","article-title":"Vaccination against atherosclerosis","volume":"59","author":"Kobiyama","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib37","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41467-017-01565-6","article-title":"A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2022.105324_bib38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41541-020-00238-8","article-title":"Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines","volume":"5","author":"Lofano","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.isci.2022.105324_bib39","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1517\/17425247.2015.1046431","article-title":"Cationic PTD\/CPP-mediated macromolecular delivery: charging into the cell","volume":"12","author":"Lonn","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.isci.2022.105324_bib40","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/cti.2016.6","article-title":"Targeting dendritic cells: a promising strategy to improve vaccine effectiveness","volume":"5","author":"Macri","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1532\/IJH97.04116","article-title":"A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma","volume":"81","author":"Maeda","year":"2005","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.isci.2022.105324_bib42","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: current progress and future challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.isci.2022.105324_bib43","doi-asserted-by":"crossref","first-page":"11980","DOI":"10.1038\/ncomms11980","article-title":"A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries","volume":"7","author":"Mann","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2022.105324_bib44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/vaccines8010132","article-title":"Development of next generation Streptococcus pneumoniae vaccines conferring broad protection","volume":"8","author":"Masomian","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.isci.2022.105324_bib45","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41591-020-0753-3","article-title":"Engineered immunogen binding to alum adjuvant enhances humoral immunity","volume":"26","author":"Moyer","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2022.105324_bib46","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI81083","article-title":"Beyond antigens and adjuvants: formulating future vaccines","volume":"126","author":"Moyer","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2022.105324_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1386207053258578","article-title":"Phage display and PEGylation of therapeutic proteins","volume":"8","author":"Mukai","year":"2005","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.isci.2022.105324_bib48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11906-018-0820-z","article-title":"Therapeutic vaccines for hypertension: a new option for clinical practice","volume":"20","author":"Nakagami","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.isci.2022.105324_bib49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2022.105324_bib50","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.immuni.2017.05.007","article-title":"Elicitation of robust tier 2 neutralizing antibody responses in nonhuman primates by HIV envelope trimer immunization using optimized approaches","volume":"46","author":"Pauthner","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2022.105324_bib51","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/CVI.00290-09","article-title":"Vaccines: the fourth century","volume":"16","author":"Plotkin","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2016.03.008","article-title":"Tumor penetrating peptides for improved drug delivery","volume":"110\u2013111","author":"Ruoslahti","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.isci.2022.105324_bib53","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.3389\/fimmu.2018.02674","article-title":"Protection against invasive infections in children caused by encapsulated bacteria","volume":"9","author":"Sadarangani","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2022.105324_bib55","doi-asserted-by":"crossref","first-page":"14655","DOI":"10.1038\/s41598-017-14709-x","article-title":"Precision targeting of tumor macrophages with a CD206 binding peptide","volume":"7","author":"Scodeller","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2022.105324_bib56","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/cas.12824","article-title":"Adjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity","volume":"106","author":"Seya","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.isci.2022.105324_bib57","doi-asserted-by":"crossref","first-page":"103131","DOI":"10.1016\/j.isci.2021.103131","article-title":"Synergistic effect of non-neutralizing antibodies and interferon-gamma for cross-protection against influenza","volume":"24","author":"Shibuya","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.isci.2022.105324_bib58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/14760584.2014.863715","article-title":"Recent progress concerning CpG DNA and its use as a vaccine adjuvant","volume":"13","author":"Shirota","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.isci.2022.105324_bib59","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1096\/fj.12-224758","article-title":"A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells","volume":"27","author":"Sioud","year":"2013","journal-title":"Faseb. J."},{"key":"10.1016\/j.isci.2022.105324_bib60","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1038\/ncomms5478","article-title":"Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis","volume":"5","author":"Sugihara","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2022.105324_bib61","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.01403-06","article-title":"Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection","volume":"75","author":"Sun","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2022.105324_bib62","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.smim.2011.01.001","article-title":"Targeted antigen delivery and activation of dendritic cells in\u00a0vivo: steps towards cost effective vaccines","volume":"23","author":"Tacken","year":"2011","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.isci.2022.105324_bib63","doi-asserted-by":"crossref","first-page":"E6639","DOI":"10.1073\/pnas.1606050113","article-title":"Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination","volume":"113","author":"Tam","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2022.105324_bib64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/B978-0-12-396962-0.00002-1","article-title":"Mapping of vascular ZIP codes by phage display","volume":"503","author":"Teesalu","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.isci.2022.105324_bib65","doi-asserted-by":"crossref","first-page":"16157","DOI":"10.1073\/pnas.0908201106","article-title":"C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration","volume":"106","author":"Teesalu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2022.105324_bib66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2011.02496.x","article-title":"Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity","volume":"271","author":"Trumpfheller","year":"2012","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.isci.2022.105324_bib67","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/imm.13019","article-title":"Basics of memory B-cell responses: lessons from and for the real world","volume":"156","author":"Wong","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.isci.2022.105324_bib68","doi-asserted-by":"crossref","first-page":"40437","DOI":"10.18632\/oncotarget.9624","article-title":"A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy","volume":"7","author":"Yan","year":"2016","journal-title":"Oncotarget"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004222015966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004222015966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:06:34Z","timestamp":1762880794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004222015966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":68,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2589004222015966"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2022.105324","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient antigen delivery by dendritic cell-targeting peptide via nucleolin confers superior vaccine effects in mice","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2022.105324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"105324"}}